BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, January 25, 2026
Home
» Products Receiving Approvable Letters From FDA
Products Receiving Approvable Letters From FDA
Jan. 1, 2000
Company
Product
Description
Indication
Action/Date
Chiroscience Group plc (UK)
Chirocaine
Levobupivacaine; chiral version of bupavicaine
Long-acting local anesthetic
Received approvable letter (3/1)
DUSA Pharmaceuticals Inc. (Canada)
Levulan
Photodynamic therapy; 20% solution of amino-levulinic acid HCl (topical)
Multiple actinic keratoses of the face and scalp
Received approvable letter (6/29)
Ergo Science Corp.
Ergoset
Bromocriptine mesylate
Type 2 diabetes
Received approvable letter for NDA (10/21)
Novartis AG (Switzerland)
Exelon
Rivastigmine tartrate capsules
Mild-to-moderate Alzheimer's disease
Received approvable letter (5/13)
Article reprints
To read more on related topics, click on one of the words below.
BioWorld MedTech
Related Articles
Products Receiving Approvable Letters From FDA
Products Receiving Approvable Letters From FDA In 2000
Products Receiving Complete Review Or Approvable Letters